av/dr-reddys--big.svg

NYSE:RDY

Dr. Reddy's Laboratories Limited

  • Stock

USD

Last Close

1,183.90

02/05 08:51

Market Cap

1.10T

Beta: 0.24

Volume Today

850.23K

Avg: 213.67K

PE Ratio

19.34

PFCF: 35.19

Dividend Yield

0.02%

Payout:12.73%

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
22.18B
-
20.01B
9.77%
12.04B
39.84%
9.81B
18.55%
18.80B
91.67%
19.50B
3.74%
19.15B
1.79%
23.57B
23.08%
60.48B
156.64%
55.68B
7.94%
depreciation and amortization
8.10B
-
10.25B
26.54%
11.28B
10.02%
11.71B
3.84%
12.19B
4.10%
12.47B
2.31%
12.80B
2.60%
11.82B
7.60%
12.50B
5.73%
14.86B
18.83%
deferred income tax
5.98B
-
7.13B
19.10%
2.61B
63.32%
4.54B
73.49%
3.65B
19.56%
-1.47B
140.19%
9.18B
725.85%
8.73B
4.85%
15.30B
75.26%
16.19B
5.79%
stock based compensation
498M
-
471M
5.42%
398M
15.50%
454M
14.07%
389M
14.32%
521M
33.93%
584M
12.09%
592M
1.37%
397M
32.94%
407M
2.52%
change in working capital
-15.04B
-
-188M
98.75%
-5.35B
2,745.74%
-8.96B
67.55%
-5.77B
35.62%
-7.54B
30.58%
-8.29B
9.98%
-13.91B
67.88%
-7.86B
43.55%
-20.18B
156.93%
accounts receivables
1.80B
-
-12.45B
792.60%
2.08B
116.72%
-17.01B
917.49%
-5.75B
66.19%
-8.05B
40.02%
inventory
-5.45B
-
-2.52B
53.70%
-6.33B
150.79%
-3.23B
48.89%
-8.50B
162.79%
-1.49B
82.50%
-9.88B
564.49%
-5.33B
46.08%
-2.65B
50.19%
-18.45B
594.99%
accounts payables
398M
-
1.58B
295.98%
2.86B
81.54%
4.41B
54.21%
23M
99.48%
3.46B
14,943.48%
other working capital
-9.59B
-
2.33B
124.33%
975M
58.23%
-5.73B
687.79%
530M
109.25%
4.82B
809.62%
-3.35B
169.47%
4.01B
219.86%
528M
86.85%
2.86B
441.10%
other non cash items
3.31B
-
3.57B
7.91%
535M
85.03%
488M
8.79%
-547M
212.09%
6.35B
1,261.24%
2.29B
64.00%
-2.69B
217.71%
-21.96B
715.60%
47.36B
315.70%
net cash provided by operating activities
25.03B
-
41.25B
64.77%
21.51B
47.84%
18.03B
16.19%
28.70B
59.21%
29.84B
3.96%
35.70B
19.64%
28.11B
21.27%
58.87B
109.45%
44.97B
23.62%
investments in property plant and equipment
-15.33B
-
-14.88B
2.95%
-40.98B
175.52%
-11.04B
73.06%
-7.49B
32.17%
-6.12B
18.37%
-12.56B
105.41%
-19.05B
51.65%
-18.86B
0.97%
-27.43B
45.44%
acquisitions net
-276M
-
-7.94B
2,775.36%
-103M
98.70%
1.75B
1,800.97%
536M
69.41%
214M
60.07%
-15.51B
7,349.53%
-326M
97.90%
23.37B
7,268.10%
1.06B
95.45%
purchases of investments
-53.47B
-
-68.25B
27.65%
-49.65B
27.25%
-68.43B
37.82%
-78.57B
14.82%
-111.92B
42.44%
-75.42B
32.61%
-88.97B
17.97%
-136.17B
53.05%
-145.50B
6.85%
sales maturities of investments
45.18B
-
69.27B
53.33%
71.59B
3.36%
64.04B
10.56%
76.29B
19.13%
111.70B
46.42%
79.53B
28.80%
77.77B
2.21%
112.81B
45.05%
129.78B
15.05%
other investing activites
989M
-
1.37B
38.22%
672M
50.84%
-1.20B
278.72%
1.51B
225.73%
1.19B
21.06%
1.30B
9.48%
4.19B
221.00%
-22.51B
637.34%
21M
100.09%
net cash used for investing activites
-22.90B
-
-20.42B
10.83%
-18.47B
9.56%
-14.88B
19.43%
-7.73B
48.08%
-4.92B
36.29%
-22.66B
360.29%
-26.39B
16.45%
-41.37B
56.79%
-42.07B
1.68%
debt repayment
-3.72B
-
-11.71B
215.02%
-5.22B
55.41%
-15.18B
-
-23.40B
54.13%
-4.50B
80.78%
-785M
82.54%
-1.01B
29.30%
-5.49B
441.18%
common stock issued
206M
-
1M
99.51%
1M
0%
1M
0%
15.18B
1,518,100%
4M
99.97%
269M
6,625%
334M
24.16%
368M
10.18%
805M
118.75%
common stock repurchased
2.98B
-
-15.69B
-
-535M
-
-474M
11.40%
-1.19B
151.69%
451M
137.80%
647M
43.46%
dividends paid
-3.59B
-
-4.11B
14.47%
-3.39B
17.44%
-3.99B
17.76%
-4.00B
0.25%
-3.92B
2.15%
-4.15B
5.90%
-4.15B
0.02%
-4.98B
20.09%
-6.65B
33.52%
other financing activites
1M
-
-1.19B
119,100%
20.61B
1,832.02%
-449M
102.18%
-16.79B
3,639.20%
2.63B
115.65%
9.27B
252.87%
1.72B
81.40%
-21.88B
1,369.26%
4.03B
118.43%
net cash used provided by financing activities
-4.12B
-
-17.00B
312.85%
-3.69B
78.28%
-4.44B
20.26%
-21.33B
380.32%
-25.16B
17.97%
-298M
98.82%
-2.42B
712.75%
-26.86B
1,009.04%
-1.50B
94.43%
effect of forex changes on cash
-1.07B
-
-4.30B
302.25%
-492M
88.55%
57M
111.59%
35M
38.60%
-25M
171.43%
113M
552%
733M
548.67%
286M
60.98%
-59M
120.63%
net change in cash
-3.06B
-
-473M
84.53%
-1.14B
141.44%
-1.24B
8.32%
-314M
74.62%
-266M
15.29%
12.86B
4,933.83%
32M
99.75%
-9.07B
28,453.13%
1.33B
114.64%
cash at beginning of period
8.45B
-
5.39B
36.17%
4.92B
8.77%
3.78B
23.21%
2.54B
32.73%
2.23B
12.35%
1.96B
11.94%
14.82B
655.35%
14.85B
0.22%
5.78B
61.09%
cash at end of period
5.39B
-
4.92B
8.77%
3.78B
23.21%
2.54B
32.73%
2.23B
12.35%
1.96B
11.94%
14.82B
655.35%
14.85B
0.22%
5.78B
61.09%
7.11B
22.98%
operating cash flow
25.03B
-
41.25B
64.77%
21.51B
47.84%
18.03B
16.19%
28.70B
59.21%
29.84B
3.96%
35.70B
19.64%
28.11B
21.27%
58.87B
109.45%
44.97B
23.62%
capital expenditure
-15.33B
-
-14.88B
2.95%
-40.98B
175.52%
-11.04B
73.06%
-7.49B
32.17%
-6.12B
18.37%
-12.56B
105.41%
-19.05B
51.65%
-18.86B
0.97%
-27.43B
45.44%
free cash flow
9.71B
-
26.37B
171.71%
-19.47B
173.83%
6.99B
135.88%
21.21B
203.65%
23.73B
11.85%
23.14B
2.46%
9.06B
60.85%
40.01B
341.65%
17.53B
56.18%

All numbers in USD (except ratios and percentages)